Biolinerx LTD. (BLRX) SEC Filings — 2024
21 SEC filings for Biolinerx LTD. (BLRX) in 2024.
Filings
- BioLineRx Ltd. Reports Q3 2024 Financial Results — 6-K · Nov 25, 2024
- BioLineRx Licenses Technology to Ayrmid Pharma — 6-K · Nov 21, 2024
- BioLineRx Gets 180-Day Nasdaq Bid Price Extension — 6-K · Nov 12, 2024
- BioLineRx Ltd. Files Form 6-K — 6-K · Nov 5, 2024
- BioLineRx Ltd. Files 6-K Reporting Press Release — 6-K · Oct 16, 2024
- BioLineRx Ltd. Reports Annual Shareholder Meeting Results — 6-K · Oct 1, 2024
- BioLineRx Sets Shareholder Meeting for October 1 — 6-K · Aug 19, 2024
- BioLineRx Ltd. Reports Q2 2024 Financial Results — 6-K · Aug 15, 2024
- BioLineRx Faces Breach of Contract Lawsuit — 6-K · Jun 18, 2024
- BioLineRx Acquires CrystaVix JAK1/2 Inhibitor Program — 6-K · May 30, 2024
- BioLineRx Ltd. Reports Q1 2024 Financial Results — 6-K · May 28, 2024
- BioLineRx Ltd. Files Form 6-K Announcing Press Release — 6-K · May 24, 2024
- BioLineRx Ltd. Files 6-K Report — 6-K · May 17, 2024
- BioLineRx Ltd. Files 6-K, Announces Press Release — 6-K · May 6, 2024
- BioLineRx Ltd. Files Form 6-K Reporting Press Release — 6-K · Apr 17, 2024
- BioLineRx Ltd. Files March 2024 Report on Form 6-K — 6-K · Apr 10, 2024
- BioLineRx Ltd. Announces Registered Direct Offering — 6-K · Apr 1, 2024
- BioLineRx Ltd. Files 20-F/A Amendment — 20-F/A · Mar 26, 2024
- BioLineRx Ltd. Files 6-K, Incorporates Press Release — 6-K · Mar 4, 2024
- BioLineRx Files 6-K, Incorporates Press Release into Registrations — 6-K · Feb 28, 2024
- BioLineRx Files 6-K, Issues Press Release on Feb 16 — 6-K · Feb 16, 2024